Medical/Pharmaceuticals
BioCina awarded Grants to develop enabling technologies for manufacture of precision mRNA vaccines
MIAMI and ADELAIDE, Australia, April 27, 2023 /PRNewswire/ -- BioCina, a leading contract development and manufacturing organization (CDMO) is pleased to announce that it has been awarded a$5.0m AUD grant under the Federal Government's Medical Research Future Fund (MRFF) Grants scheme to fund wor...
MGI and South Australian Genomics Centre Introduce DNBSEQ-T7* to Supercharge Genomics Research in Australia
BRISBANE, Australia, April 27, 2023 /PRNewswire/ -- MGI
Antengene to Release Latest Results from the TORCH-2 Trial of mTORC1/2 Inhibitor ATG-008 in Poster Discussion at 2023 ASCO
SHANGHAI and HONG KONG, April 27, 2023 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer, today announ...
Telix Accelerates Artificial Intelligence (AI) Development Program with Acquisition of Dedicaid
MELBOURNE, Australia, April 27, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the expansion of its artificial intelligence (AI) capability with the signing of an agreement to acquireVienna-based Dedicaid GmbH (Dedicaid), a spin-off of the Medica...
MGI Announces New Customer Experience Center in South Korea with BMS
CHEONAN, South Korea, April 26, 2023 /PRNewswire/ -- MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, today celebrated the opening of its Customer Experience Center (CEC) inSouth Korea. In partnership with one of the country's leading compan...
MGI Secured First Corporate Order of Ultra-high Throughput Sequencer DNBSEQ-T20×2*
SHANGHAI, April 26, 2023 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a global life science tools leader, announced its partnership with Shanghai-based JMDNA Biomedical Technology Co., Ltd. ("JMDNA") for DNBSEQ-T20×2 ("T20"), a sequencer that broke records for its ultra-high throughput and cost-ef...
RemeGen Celebrates World Intellectual Property Day 2023
YANTAI, China, April 26, 2023 /PRNewswire/ -- RemeGen Co., Ltd.
Bridgewest Perth Pharma to commercialize Sterile Injectable drugs under LumaCina business unit
MIAMI and PERTH, Australia, April 26, 2023 /PRNewswire/ -- Global private investment firm,Bridgewest Group, recognized for developing innovative companies in life sciences, software, and deep tech, establishes LumaCina business unit under Bridgewest Perth Pharma inPerth, Australia. The newly cre...
Bioved Pharmaceuticals granted a US Patent for its oral, natural plant-based product, Artovid-20® for the treatment of Covid-19
SAN JOSE, Calif., April 26, 2023 /PRNewswire/ -- Bioved Pharmaceuticals, Inc. is proud to announce that it has received a US Patent for its natural Ayurved based product, Artovid-20® Tablets for Covid-19. The Patent titled "Methods and Compounds for Treating Effects of Covid-19 Disease," grants 2...
IF YOU, A CHILD IN YOUR CARE, OR ANOTHER LOVED ONE WERE HARMED BY ENDO OR A RELATED COMPANY, INCLUDING PAR OR AMS, OR THEIR PRODUCTS INCLUDING OPIOIDS, RANITIDINE, OR TRANSVAGINAL MESH, YOUR RIGHTS MAY BE AFFECTED BY DEADLINES IN THE ENDO BANKRUPTCY.
The deadline to file a claim in the bankruptcy is July 7, 2023, at 5:00 p.m. (prevailing Eastern Time). The deadline to object to Endo's sale is July 7, 2023, at 4:00 p.m. (prevailing Eastern Time). NEW YORK, April 25, 2023 /PRNewswire/ -- The following is being issued by Kroll Restructuring Adm...
ZEISS Announces U.S. FDA Approval of the CT LUCIA 621P Monofocal IOL, Offering the Unique ZEISS Optic to the U.S. Market
The monofocal IOL enables surgeons to treat a wide range of cataract patients while supporting optimized visual outcomes. JENA, Germany and DUBLIN, Calif., April 25, 2023 /PRNewswire/ -- Today, ZEISS Medical Technology announced the U.S. Food and Drug Administration (FDA) has approved theCT LUCI...
Emmes Applauded by Frost & Sullivan for Streamlining Clinical Trials and for Its Competitive Strategies
Emmes collaborates with pharmaceutical companies as strategic partners, providing one-stop clinical trial services, reducing costs, and accelerating development. SAN ANTONIO, April 25, 2023 /PRNewswire/ -- Frost & Sullivan researched the contract research organizations industry and, based on its...
Wellcome Leap & Temasek Trust Launch US$60M Dynamic Resilience Programme to Extend Health Spans
* Average human life expectancy has doubled from 35 to 70 years over the past century[1], but health spans (number of years spent in good health) have not correspondingly improved[2] * Multimorbidity (multiple coexisting health conditions) poses an urgent challenge for global health service...
Nippon Express (UK) Receives IATA CEIV Pharma Certification for Its Facility in Heathrow Airport Suburb
TOKYO, April 25, 2023 /PRNewswire/ -- Nippon Express (UK) Ltd. (hereinafter "NXUK"), a group company of NIPPON EXPRESS HOLDINGS, INC., has been awarded IATA CEIV Pharma certification*, a quality certificate for pharmaceutical transport established by the International Air Transport Association (I...
Biotech firm Gene Solutions: A promising picture for multi-cancer early detection in Southeast Asia
HO CHI MINH CITY, Vietnam, April 25, 2023 /PRNewswire/ -- In January 2023,
Vietnam's Medical Genetics Institute & Gene Solutions
Mediso launches next generation MRI spectrometer spinScan®
BUDAPEST, Hungary, April 25, 2023 /PRNewswire/ -- Mediso
Medical Aesthetics and Technology Leader Cynosure Appoints Nadav Tomer as its Chief Executive Officer
Seasoned med-tech executive to advance Cynosure's growth and innovation strategy and strengthen the company's position as the medical aesthetics technology leader WESTFORD, Mass., April 24, 2023 /PRNewswire/ -- Cynosure, LLC ("Cynosure" or the "Company"), a leader in medical aesthetics systems a...
BMC H-80 series: empowering breathing solutions for breathing and oxygen therapy
BEIJING, April 24, 2023 /PRNewswire/ -- Recently, the H-80 series Respiratory High-Flow Therapy Device has added more comprehensive monitoring indicators for even greater convenience and efficiency to help people in respiratory failure. April is a crucial month to prioritize the respiratory hea...
Daewoong Pharmaceutical Announce Publication of Phase 3 Study of 'Envlo', a New Treatment for Diabetes, in the International SCIE Journal
SEOUL, South Korea, April 24, 2023 /PRNewswire/ -- The research results of Daewoong Pharmaceutical's SGLT-2 inhibitor new drug, 'Envlo', have been internationally acknowledged. On April 4, Daewoong Pharmaceutical (CEO Seng-ho Jeon and Chang-jae Lee) announced that the efficacy and safety evalu...
Belief BioMed Announces a Key Milestone of Dosing Completion for All Subjects in its Registrational Clinical Trial of BBM-H901
SHANGHAI, April 24, 2023 /PRNewswire/ -- Belief BioMed Group (BBM), an industry-leading biotech company focusing on innovative gene therapies, announced today the completion of patient dosing in its Phase III Registrational Clinical Trial (CTR20212816) of BBM-H901, a gene therapy for Hemophilia ...
Week's Top Stories
Most Reposted
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality
[Picked up by 321 media titles]
2024-05-17 07:00Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 319 media titles]
2024-05-15 12:00Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 303 media titles]
2024-05-16 15:00US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
[Picked up by 274 media titles]
2024-05-16 09:39Trip.com Group and Rezdy Join Forces to Offer New Travel Experiences Around the World
[Picked up by 229 media titles]
2024-05-14 18:07